- Home
- MLKN vs CLDX Comparison
MLKN vs CLDX Comparison
Compare MLKN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- CLDX
- Stock Information
- Founded
- MLKN 1905
- CLDX N/A
- Country
- MLKN United States
- CLDX United States
- Employees
- MLKN N/A
- CLDX N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MLKN Consumer Discretionary
- CLDX Health Care
- Exchange
- MLKN Nasdaq
- CLDX Nasdaq
- Market Cap
- MLKN 1.1B
- CLDX 1.3B
- IPO Year
- MLKN N/A
- CLDX 2008
- Fundamental
- Price
- MLKN $17.10
- CLDX $19.87
- Analyst Decision
- MLKN
- CLDX Buy
- Analyst Count
- MLKN 0
- CLDX 9
- Target Price
- MLKN N/A
- CLDX $50.00
- AVG Volume (30 Days)
- MLKN 371.1K
- CLDX 914.2K
- Earning Date
- MLKN 06-25-2025
- CLDX 05-08-2025
- Dividend Yield
- MLKN 4.36%
- CLDX N/A
- EPS Growth
- MLKN N/A
- CLDX N/A
- EPS
- MLKN 0.43
- CLDX N/A
- Revenue
- MLKN $3,597,000,000.00
- CLDX $7,559,000.00
- Revenue This Year
- MLKN $1.97
- CLDX N/A
- Revenue Next Year
- MLKN $3.05
- CLDX N/A
- P/E Ratio
- MLKN $40.43
- CLDX N/A
- Revenue Growth
- MLKN N/A
- CLDX 24.49
- 52 Week Low
- MLKN $15.25
- CLDX $14.40
- 52 Week High
- MLKN $31.73
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- MLKN 51.26
- CLDX 51.01
- Support Level
- MLKN $16.13
- CLDX $18.55
- Resistance Level
- MLKN $17.19
- CLDX $20.67
- Average True Range (ATR)
- MLKN 0.45
- CLDX 1.19
- MACD
- MLKN 0.01
- CLDX -0.06
- Stochastic Oscillator
- MLKN 54.19
- CLDX 52.63
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.